Product Description
Discover the superlative Geftinib Tablets IP 250mgyour paragon in NSCLC treatmentat an unbeatable price! Instant savings now on new release packs of 10 or 30 first-class, film-coated, round tablets. Each tablet contains a precise 250mg Gefitinib dose, ensuring optimum efficacy and bioequivalence for oral use. Marketed by premier exporters, suppliers, and wholesalers, Geftinib Tablets IP comply with IP standards and offer immediate release for reliable results. Odorless and easy-to-swallow, these tablets arrive in protective packaging to safeguard potency for 36 months. Prescription required.
Exceptional Application & Surface Features
Geftinib Tablets IP 250mg are specifically formulated for the oral treatment of non-small cell lung cancer. Their film-coated, round surface ensures easy swallowing and protection from moisture, guaranteeing an optimal therapeutic experience. The tablets are bioequivalent, white to off-white in color, and odorless, making administration straightforward. Intended for direct oral use, these tablets maximize absorption and deliver consistent, reliable performance, establishing them as a first-class product for targeted cancer therapy.
Sample Availability, Main Market & Certifications
Sample availability ensures healthcare professionals can assess quality before bulk procurement. Geftinib Tablets IP 250mg are delivered across India using trusted transport services, ensuring prompt arrival of shipped goods. With a well-managed outlay, both distributors and buyers benefit from streamlined procurement processes. The tablets achieve certification under the Indian Pharmacopoeia (IP) standards, verifying their safety and efficacy for prescription use, ensuring dependable results for healthcare distributors and providers nationwide.
FAQs of Geftinib Tablets IP 250mg:
Q: How should Geftinib Tablets IP 250mg be administered?
A: Geftinib Tablets IP 250mg are intended for oral administration only. They should be taken as directed by a healthcare professional, ideally at the same time each day to maintain consistent levels in the bloodstream.
Q: What is the primary benefit of using Geftinib Tablets IP 250mg?
A: The main benefit of Geftinib Tablets IP 250mg is its effectiveness in the treatment of non-small cell lung cancer (NSCLC), providing targeted therapy that can help slow the progression of the disease.
Q: When should I consider using this medication?
A: This medication should be considered when prescribed by a qualified healthcare professional for patients diagnosed with non-small cell lung cancer, following an appropriate medical evaluation.
Q: Where can I purchase Geftinib Tablets IP 250mg?
A: Geftinib Tablets IP 250mg are available through certified exporters, suppliers, wholesalers, and traders within India. A valid prescription is required before purchasing.
Q: What are the storage instructions for this product?
A: Store Geftinib Tablets IP 250mg below 30C. Keep the tablets protected from moisture and light to maintain their effectiveness throughout the shelf life.
Q: What makes these tablets a first-class option in cancer treatment?
A: These tablets adhere to Indian Pharmacopoeia standards, are bioequivalent for reliable absorption, and feature a film coating for ease of swallowing, establishing them as a premier choice for oral cancer therapy.